Published in Vaccine Weekly, April 1st, 2009
“Drug discovery and clinical trials entail years of work and millions of start-up dollars,” said Jason Burke, Worldwide Director of Health and Life Sciences at SAS. “For small and midsize firms with limited capital and staffing, ease of regulatory compliance, analysis and insight is paramount. And new drugs from these startup firms are driving growth at many top...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.